Abstract PS9-54: Healthcare costs for metastatic breast cancer patients treated with human epidermal growth factor receptor 2 targeted agents
2018 ◽
2019 ◽
2017 ◽
2017 ◽
2014 ◽
Vol 50
(5)
◽
pp. 885-891
◽
2018 ◽